• DOI:10.3389/fphar.2017.00372
Corpus ID: 35793372

Statins and New-Onset Diabetes Mellitus: LDL Receptor May Provide a Key Link

@article{Yu2017StatinsAN,
  title={Statins and New-Onset Diabetes Mellitus: LDL Receptor May Provide a Key Link},
  author={Q. Yu and Y. Chen and Cang-Bao Xu},
  journal={Frontiers in Pharmacology},
  year={2017},
  volume={8}
}

• Q. Yu, Y. Chen, Cang-Bao Xu
• Published 2017
• Medicine
• Frontiers in Pharmacology

Numerous studies have noted that populations treated with statins have increased risk for new-onset diabetes mellitus; however, the underlying molecular mechanisms are not fully understood. Interestingly, familial hypercholesterolemia (FH) patients with mutations in the low-density lipoprotein receptor (LDLR) gene are protected against diabetes mellitus (DM), despite these patients being subjected to long-term statin therapy. Since the common pathway between FH and statin therapy is LDLR… Expand

View on PubMed

frontiersin.org

Save to Library

Create Alert

Cite

Launch Research Feed